LATIN AMERICA COUGH SYRUP MARKET 2022-2028

 

 TABLE OF CONTENTS

1.     LATIN AMERICA COUGH SYRUP MARKET - SUMMARY

2.     INDUSTRY OUTLOOK

2.1. IMPACT OF COVID-19 ON THE COUGH SYRUP MARKET

2.2. KEY INSIGHTS

2.2.1.    INCREASING DEMAND FOR HERBAL COUGH SYRUPS

2.2.2.    COMPANIES PROVIDE SUGAR-FREE COUGH SYRUPS

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1.    THREAT OF NEW ENTRANTS

2.3.2.    THREAT OF SUBSTITUTES

2.3.3.    BARGAINING POWER OF BUYERS

2.3.4.    BARGAINING POWER OF SUPPLIERS

2.3.5.    THREAT OF COMPETITIVE RIVALRY

2.4. MARKET ATTRACTIVENESS INDEX

2.5. VENDOR SCORECARD

2.6. KEY MARKET STRATEGIES

2.6.1.    MERGERS & ACQUISITIONS

2.6.2.    DIVESTITURES

2.7. MARKET DRIVERS

2.7.1.    INCREASING CHRONIC RESPIRATORY DISEASES

2.7.2.    RISE IN OLDER POPULATION

2.8. MARKET CHALLENGES

2.8.1.    OVERDOSE RISK

2.8.2.    STRICT GOVERNMENT REGULATIONS AND RESTRICTIONS

2.9. MARKET OPPORTUNITIES

2.9.1.    INCREASE IN CHILD-FRIENDLY COUGH SYRUP FLAVORS

2.9.2.    GROWING PREFERENCE FOR HOMEOPATHIC COUGH SYRUPS

2.9.3.    SPECIAL PEDIATRIC COUGH SYRUPS

3.     LATIN AMERICA COUGH SYRUP MARKET OUTLOOK - BY PRODUCT TYPE

3.1. COUGH SUPPRESSANTS/ANTITUSSIVES

3.2. COMBINATION MEDICATIONS

3.3. EXPECTORANTS

4.     LATIN AMERICA COUGH SYRUP MARKET OUTLOOK - BY AGE GROUP

4.1. ADULT

4.2. PEDIATRIC

5.     LATIN AMERICA COUGH SYRUP MARKET OUTLOOK - BY DISTRIBUTION CHANNEL

5.1. RETAIL PHARMACY

5.2. HOSPITAL PHARMACY

5.3. ONLINE PHARMACY

6.     LATIN AMERICA COUGH SYRUP MARKET – COUNTRY OUTLOOK

6.1. BRAZIL

6.2. MEXICO

6.3. REST OF LATIN AMERICA

7.     COMPETITIVE LANDSCAPE

7.1. ABBOTT LABORATORIES

7.2. ACELLA PHARMACEUTICALS LLC

7.3. ASTRAZENECA PLC

7.4. CIPLA LIMITED

7.5. DABUR INDIA LTD

7.6. GLAXOSMITHKLINE

7.7. GLENMARK PHARMACEUTICALS LIMITED

7.8. JOHNSON AND JOHNSON

7.9. MERCK KGAA

7.10.               NOVARTIS INTERNATIONAL AG

7.11.               PFIZER INC

7.12.               PROCTOR AND GAMBLE CO

7.13.               RECKITT BENCKISER GROUP PLC

7.14.               SANOFI SA

7.15.               THE HIMALAYA DRUG COMPANY

8.     RESEARCH METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE & DELIVERABLES

8.2. SOURCES OF DATA

8.3. RESEARCH METHODOLOGY

         

 

 

LIST OF TABLES

TABLE 1: LATIN AMERICA COUGH SYRUP MARKET, BY COUNTRY, 2022-2028 (IN $ MILLION)

TABLE 2: VENDOR SCORECARD

TABLE 3: THE COUNTRIES WITH THE LARGEST PERCENTAGE OF TOTAL POPULATION OVER 65 YEARS IN 2020

TABLE 4: LATIN AMERICA COUGH SYRUP MARKET, BY PRODUCT TYPE, 2022-2028 (IN $ MILLION)

TABLE 5: LATIN AMERICA COUGH SYRUP MARKET, BY AGE GROUP, 2022-2028 (IN $ MILLION)

TABLE 6: LATIN AMERICA COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2022-2028 (IN $ MILLION)

TABLE 7: LATIN AMERICA COUGH SYRUP MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

 

 

LIST OF FIGURES

FIGURE 1: MARKET ATTRACTIVENESS INDEX

FIGURE 2: LATIN AMERICA COUGH SYRUP MARKET, BY PRODUCT TYPE, 2021 & 2028 (IN %)

FIGURE 3: LATIN AMERICA COUGH SYRUP MARKET, BY COUGH SUPPRESSANTS/ANTITUSSIVES, 2022-2028 (IN $ MILLION)

FIGURE 4: LATIN AMERICA COUGH SYRUP MARKET, BY COMBINATION MEDICATIONS, 2022-2028 (IN $ MILLION)

FIGURE 5: LATIN AMERICA COUGH SYRUP MARKET, BY EXPECTORANTS, 2022-2028 (IN $ MILLION)

FIGURE 6: LATIN AMERICA COUGH SYRUP MARKET, BY AGE GROUP, 2021 & 2028 (IN %)

FIGURE 7: LATIN AMERICA COUGH SYRUP MARKET, BY ADULT, 2022-2028 (IN $ MILLION)

FIGURE 8: LATIN AMERICA COUGH SYRUP MARKET, BY PEDIATRIC, 2022-2028 (IN $ MILLION)

FIGURE 9: LATIN AMERICA COUGH SYRUP MARKET, BY DISTRIBUTION CHANNELS, 2021 & 2028 (IN %)

FIGURE 10: LATIN AMERICA COUGH SYRUP MARKET, BY RETAIL PHARMACY, 2022-2028 (IN $ MILLION)

FIGURE 11: LATIN AMERICA COUGH SYRUP MARKET, BY HOSPITAL PHARMACY, 2022-2028 (IN $ MILLION)

FIGURE 12: LATIN AMERICA COUGH SYRUP MARKET, BY ONLINE PHARMACY, 2022-2028 (IN $ MILLION)

FIGURE 13: LATIN AMERICA COUGH SYRUP MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)

FIGURE 14: BRAZIL COUGH SYRUP MARKET 2022-2028 (IN $ MILLION)

FIGURE 15: MEXICO COUGH SYRUP MARKET 2022-2028 (IN $ MILLION)

FIGURE 16: REST OF LATIN AMERICA COUGH SYRUP MARKET 2022-2028 (IN $ MILLION)

 

 

MARKET OUTLOOK

Triton’s research report states that the Latin American cough syrup market is estimated to register progress at a compound annual growth rate of 2.36% during the forecast period 2022-2028. Brazil, Mexico, and Rest of Latin America outline the market in this region.

Air pollution causes a majority of deaths in Mexico. Chronic lung disease, acute respiratory infections, heart disease, and lung cancer are highly prevalent conditions caused by rising pollution levels. In 2019, the country reported a high number of acute respiratory infections. Furthermore, asthma prevalence in Mexican adults has surged substantially in the last few years. Therefore, the rise in respiratory diseases contributes to the growth of the cough syrup market across the country.

Furthermore, asthma is a widespread disease among adults in Argentina. Moreover, COPD is highly prevalent in the country’s population. As per WHO data, lung disease in the country has caused a significant amount of deaths in recent years. Besides this, Argentina and Chile have witnessed a substantial rise in the older population. Therefore, the rise in the older population is expected to widen the scope of the cough syrup market across the region.

 

Get more Insights into the Latin America Cough Syrup Market:

 

https://www.tritonmarketresearch.com/reports/latin-america-cough-syrup-market

 

 

COMPETITIVE OUTLOOK

The major companies in the cough syrup market include Abbott Laboratories, AstraZeneca Plc, Cipla Limited, Johnson and Johnson, and Pfizer Inc.

 

 

SEGMENTATION

1.     ABBOTT LABORATORIES

2.     ACELLA PHARMACEUTICALS LLC

3.     ASTRAZENECA PLC

4.     CIPLA LIMITED

5.     DABUR INDIA LTD

6.     GLAXOSMITHKLINE

7.     GLENMARK PHARMACEUTICALS LIMITED

8.     JOHNSON AND JOHNSON

9.     MERCK KGAA

10. NOVARTIS INTERNATIONAL AG

11. PFIZER INC

12. PROCTOR AND GAMBLE CO

13. RECKITT BENCKISER GROUP PLC

14. SANOFI SA

15. THE HIMALAYA DRUG COMPANY